Abstract
Purpose
In a sample of outpatients with breast, gastrointestinal, gynecological, and lung cancer who received at least two cycles of chemotherapy (CTX), the purposes were to evaluate for inter-individual differences in the severity of sleep disturbance and determine which demographic, clinical, and symptom characteristics were associated with initial levels as well as the trajectories of sleep disturbance.
Methods
A total of 1331 patients completed study questionnaires in their homes, at six time points over two cycles of CTX (prior to CTX administration, approximately 1 week after CTX administration, and approximately 2 weeks after CTX administration). Questionnaires included demographic, clinical, and symptom assessments (i.e., General Sleep Disturbance Scale, Lee Fatigue Scale, Center for Epidemiological Studies-Depression Scale, Spielberger State-Trait Anxiety Inventories, Attentional Function Index). Hierarchical linear modeling based on full maximum likelihood estimation was performed.
Results
Characteristics associated with higher initial levels of sleep disturbance included higher body mass index, poorer functional status, higher trait anxiety, higher depressive symptoms, and higher evening fatigue. Characteristics associated with the worse trajectories of sleep disturbance were higher levels of education and higher sleep disturbance at enrollment. Characteristics associated with both higher initial levels and worse trajectories of sleep disturbance were higher morning fatigue and worse attentional function.
Conclusions
A large amount of inter-individual variability exists in sleep disturbance during CTX. The modifiable and non-modifiable characteristics found in this study can be used to identify higher risk patients and provide earlier interventions to reduce sleep disturbance.
Similar content being viewed by others
References
Knobf MT, Cooley ME, Duffy S et al (2015) The 2014-2018 Oncology Nursing Society Research Agenda. Oncol Nurs Forum 42(5):450–465. doi:10.1188/15.ONF.450-465
Enderlin CA, Coleman EA, Cole C, Richards KC, Hutchins LF, Sherman AC (2010) Sleep across chemotherapy treatment: a growing concern for women older than 50 with breast cancer. Oncol Nurs Forum 37(4):461–A463
Vena C, Parker K, Cunningham M, Clark J, McMillan S (2004) Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum 31(4):735–746. doi:10.1188/04.ONF.735-746
Sanford SD, Wagner LI, Beaumont JL, Butt Z, Sweet JJ, Cella D (2013) Longitudinal prospective assessment of sleep quality: before, during, and after adjuvant chemotherapy for breast cancer. Support Care Cancer 21(4):959–967. doi:10.1007/s00520-012-1612-7
Wright F, D'Eramo Melkus G, Hammer M, Schmidt BL, Knobf MT, Paul SM, Cartwright F, Mastick J, Cooper BA, Chen LM, Melisko M, Levine JD, Kober K, Aouizerat BE, Miaskowski C (2015) Predictors and trajectories of morning fatigue are distinct from evening fatigue. J Pain Symptom Manag 50(2):176–189. doi:10.1016/j.jpainsymman.2015.02.016
Miaskowski C, Cooper BA, Melisko M, Chen LM, Mastick J, West C, Paul SM, Dunn LB, Schmidt BL, Hammer M, Cartwright F, Wright F, Langford DJ, Lee K, Aouizerat BE (2014) Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy. Cancer 120(15):2371–2378. doi:10.1002/cncr.28699
Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) AUDIT: the Alcohol Use Disorders Identification Test: guidelines for use in primary care. World Health Organization, Geneva
Karnofsky D (1977) Performance scale. Factors that influence the therapeutic response in cancer: a comprehensive treatise. Plenum Press, New York
Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The self-administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49(2):156–163. doi:10.1002/art.10993
Fletcher BS, Paul SM, Dodd MJ, Schumacher K, West C, Cooper B, Lee K, Aouizerat B, Swift P, Wara W, Miaskowski CA (2008) Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol 26(4):599–605. doi:10.1200/JCO.2007.12.2838
Lee KA (1992) Self-reported sleep disturbances in employed women. Sleep 15(6):493–498
Lee KA, Hicks G, Nino-Murcia G (1991) Validity and reliability of a scale to assess fatigue. Psychiatry Res 36(3):291–298
Spielberger CG, Gorsuch RL, Suchene R, Vagg PR, Jacobs GA (1983) Manual for the state-anxiety (form Y): self evaluation questionnaire. Consulting Psychologists Press, Palo Alto, CA
Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401
Cimprich B, Visovatti M, Ronis DL (2011) The Attentional Function Index—a self-report cognitive measure. Psychooncology 20(2):194–202. doi:10.1002/pon.1729
Daut RL, Cleeland CS, Flanery RC (1983) Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 17(2):197–210
Raudenbush SW, Bryk A (2002) Hierarchical linear models: applications and data analysis methods, 2nd edn. Sage Publications, Thousand Oaks, CA
Wright F, D'Eramo Melkus G, Hammer M, Schmidt BL, Knobf MT, Paul SM, Cartwright F, Mastick J, Cooper BA, Chen LM, Melisko M, Levine JD, Kober K, Aouizerat BE, Miaskowski C (2015) Trajectories of evening fatigue in oncology outpatients receiving chemotherapy. J Pain Symptom Manag 50(2):163–175. doi:10.1016/j.jpainsymman.2015.02.015
Osborne C, Berger LM, Magnuson K (2012) Family structure transitions and changes in maternal resources and well-being. Demography 49(1):23–47. doi:10.1007/s13524-011-0080-x
Liu L, Ancoli-Israel S (2008) Sleep disturbances in cancer. Psychiatr Ann 38(9):627–634
Savard J, Morin CM (2001) Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 19(3):895–908
Van Onselen C, Paul SM, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Cooper B, Miaskowski C (2013) Trajectories of sleep disturbance and daytime sleepiness in women before and after surgery for breast cancer. J Pain Symptom Manag 45(2):244–260. doi:10.1016/j.jpainsymman.2012.02.020
Elwood LS, Wolitzky-Taylor K, Olatunji BO (2012) Measurement of anxious traits: a contemporary review and synthesis. Anxiety Stress Coping 25(6):647–666. doi:10.1080/10615806.2011.582949
Van Onselen C, Cooper BA, Lee K, Dunn L, Aouizerat BE, West C, Dodd M, Paul S, Miaskowski C (2012) Identification of distinct subgroups of breast cancer patients based on self-reported changes in sleep disturbance. Support Care Cancer 20(10):2611–2619. doi:10.1007/s00520-012-1381-3
Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L (2010) Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 18(1):105–114. doi:10.1007/s00520-009-0636-0
Dhruva A, Dodd M, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Swift PS, Wara W, Miaskowski C (2010) Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs 33(3):201–212. doi:10.1097/NCC.0b013e3181c75f2a
World Health Organization (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Techinical Report Series 894:1–253
Hargens TA, Kaleth AS, Edwards ES, Butner KL (2013) Association between sleep disorders, obesity, and exercise: a review. Nat Sci Sleep 5:27–35. doi:10.2147/NSS.S34838
Mishra SI, Scherer RW, Snyder C, Geigle PM, Berlanstein DR, Topaloglu O (2012) Exercise interventions on health-related quality of life for people with cancer during active treatment. Cochrane Database Syst Rev 8:CD008465. doi:10.1002/14651858.CD008465.pub2
Johansson A, Adamson A, Ejdeback J, Edell-Gustafsson U (2014) Evaluation of an individualised programme to promote self-care in sleep-activity in patients with coronary artery disease—a randomised intervention study. J Clin Nurs 23(19–20):2822–2834. doi:10.1111/jocn.12546
Miaskowski C, Paul SM, Cooper BA, Lee K, Dodd M, West C, Aouizerat BE, Dunn L, Swift PS, Wara W (2011) Predictors of the trajectories of self-reported sleep disturbance in men with prostate cancer during and following radiation therapy. Sleep 34(2):171–179
Huang TW, Lin CC (2009) The mediating effects of depression on sleep disturbance and fatigue: symptom clusters in patients with hepatocellular carcinoma. Cancer Nurs 32(5):398–403. doi:10.1097/NCC.0b013e3181ac6248
Palesh O, Peppone L, Innominato PF, Janelsins M, Jeong M, Sprod L, Savard J, Rotatori M, Kesler S, Telli M, Mustian K (2012) Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer. Nat Sci Sleep 4:151–162. doi:10.2147/NSS.S18895
Irwin MR, Olmstead RE, Ganz PA, Haque R (2013) Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun 30(Suppl):S58–S67. doi:10.1016/j.bbi.2012.05.002
Tomlinson D, Diorio C, Beyene J, Sung L (2014) Effect of exercise on cancer-related fatigue: a meta-analysis. Am J Phys Med Rehabil 93(8):675–686. doi:10.1097/PHM.0000000000000083
Fleming L, Randell K, Harvey CJ, Espie CA (2014) Does cognitive behaviour therapy for insomnia reduce clinical levels of fatigue, anxiety and depression in cancer patients? Psychooncology 23(6):679–684. doi:10.1002/pon.3468
Berger AM, Mitchell SA, Jacobsen PB, Pirl WF (2015) Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice? CA Cancer J Clin 65(3):190–211. doi:10.3322/caac.21268
Davis MP, Goforth H (2014) Fighting insomnia and battling lethargy: the yin and yang of palliative care. Curr Oncol Rep 16(4):377. doi:10.1007/s11912-014-0377-1
Lee KA, Lipscomb J (2003) Sleep among shiftworkers—a priority for clinical practice and research in occupational health nursing. AAOHN J 51(10):418–420
Gay CL, Lee KA, Lee SY (2004) Sleep patterns and fatigue in new mothers and fathers. Biol Res Nurs 5(4):311–318. doi:10.1177/1099800403262142
Myers JS, Wick JA, Klemp J (2015) Potential factors associated with perceived cognitive impairment in breast cancer survivors. Support Care Cancer 23(11):3219–3228. doi:10.1007/s00520-015-2708-7
Henneghan A (2016) Modifiable factors and cognitive dysfunction in breast cancer survivors: a mixed-method systematic review. Support Care Cancer 24(1):481–497. doi:10.1007/s00520-015-2927-y
Caplette-Gingras A, Savard J, Savard MH, Ivers H (2013) Is insomnia associated with cognitive impairments in breast cancer patients? Behav Sleep Med 11(4):239–257. doi:10.1080/15402002.2012.672940
Fardell JE, Vardy J, Johnston IN, Winocur G (2011) Chemotherapy and cognitive impairment: treatment options. Clin Pharmacol Ther 90(3):366–376. doi:10.1038/clpt.2011.112
Langford DJ, Lee K, Miaskowski C (2012) Sleep disturbance interventions in oncology patients and family caregivers: a comprehensive review and meta-analysis. Sleep Med Rev 16(5):397–414. doi:10.1016/j.smrv.2011.07.002
Acknowledgements
This study was funded by the National Cancer Institute (NCI, CA134900). Dr. Miaskowski is supported by a grant from the American Cancer Society and NCI (CA168960). Dr. Sueann Mark was supported by a Graduate Scholarship in Cancer Nursing Practice, GSCNP-15-110-01 from the American Cancer Society.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Supplementary Table 1
(DOCX 25 kb)
Rights and permissions
About this article
Cite this article
Mark, S., Cataldo, J., Dhruva, A. et al. Modifiable and non-modifiable characteristics associated with sleep disturbance in oncology outpatients during chemotherapy. Support Care Cancer 25, 2485–2494 (2017). https://doi.org/10.1007/s00520-017-3655-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-017-3655-2